Latest Health News
Bavarian Nordic and Serum Institute of India Expand Strategic Partnership with Chikungunya Vaccine Manufacturing Agreement
The agreement enables a full tech transfer of the chikungunya vaccine for…
Propr Introduces Propr Paste, Completing Its Clinically Inspired System for Gentle, Long-Term Oral Health
New York, NY, March 11, 2026 (GLOBE NEWSWIRE) -- Propr®, the fluoride…
Natural Remedies Advances Sleep Health Research with Holixer During National Sleep Awareness Month
BANGALORE, India, March 10, 2026 (GLOBE NEWSWIRE) -- During National Sleep Awareness…
NKGen Biotech to Present Integrated Phase 1 Clinical and Biomarker Analyses for Troculeucel in Alzheimers Disease at AD/PD 2026
March 10, 2026 08:05 ET | Source: NKGen Biotech, Inc. SANTA ANA,…
API Innovation Center Highlights Fragility in U.S. Drug Supply Chain in New White Paper
ST. LOUIS, March 10, 2026 (GLOBE NEWSWIRE) -- The API Innovation Center (APIIC),…
Surgery Partners, Inc. to Present at Upcoming Investor Conference
March 09, 2026 12:04 ET | Source: Surgery Partners, Inc. BRENTWOOD, Tenn.,…
Zealand Pharma to participate in upcoming investor conferences in March 2026
March 09, 2026 12:01 ET | Source: Zealand Pharma Press release –…
CORRECTING & REPLACING — MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
Following End-of-Phase 2 meeting, MBX remains on track to initiate Phase 3…
Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026
March 08, 2026 14:00 ET | Source: Xenon Pharmaceuticals Inc. VANCOUVER, British…
